[PDF][PDF] Enzalutamid v léčbě metastatického kastračně rezistentního karcinomu prostaty

I Richter, J Dvořák - Onkologie, 2019 - solen.cz
Metastatic castration-resistant prostate cancer is a severe disease. Recently, however, its
therapy has been significantly enriched adding novel treatment options extending patient …

[引用][C] Targeting IGF-1/2 with xentuzumab plus enzalutamide in metastatic castration-resistant prostate cancer after progression on docetaxel chemotherapy and …

S Hussain, JP Maroto, MÁ Climent, D Bianchini…